1. Home
  2. TECX vs FDBC Comparison

TECX vs FDBC Comparison

Compare TECX & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • FDBC
  • Stock Information
  • Founded
  • TECX 2019
  • FDBC 1902
  • Country
  • TECX United States
  • FDBC United States
  • Employees
  • TECX N/A
  • FDBC N/A
  • Industry
  • TECX
  • FDBC Major Banks
  • Sector
  • TECX
  • FDBC Finance
  • Exchange
  • TECX Nasdaq
  • FDBC Nasdaq
  • Market Cap
  • TECX 334.4M
  • FDBC 238.0M
  • IPO Year
  • TECX 2018
  • FDBC N/A
  • Fundamental
  • Price
  • TECX $21.69
  • FDBC $48.59
  • Analyst Decision
  • TECX Buy
  • FDBC
  • Analyst Count
  • TECX 6
  • FDBC 0
  • Target Price
  • TECX $78.67
  • FDBC N/A
  • AVG Volume (30 Days)
  • TECX 241.7K
  • FDBC 9.6K
  • Earning Date
  • TECX 08-13-2025
  • FDBC 07-23-2025
  • Dividend Yield
  • TECX N/A
  • FDBC 3.29%
  • EPS Growth
  • TECX N/A
  • FDBC 32.34
  • EPS
  • TECX N/A
  • FDBC 3.75
  • Revenue
  • TECX N/A
  • FDBC $81,316,000.00
  • Revenue This Year
  • TECX N/A
  • FDBC N/A
  • Revenue Next Year
  • TECX N/A
  • FDBC N/A
  • P/E Ratio
  • TECX N/A
  • FDBC $12.96
  • Revenue Growth
  • TECX N/A
  • FDBC 15.07
  • 52 Week Low
  • TECX $13.70
  • FDBC $37.00
  • 52 Week High
  • TECX $61.07
  • FDBC $61.21
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.82
  • FDBC 71.22
  • Support Level
  • TECX $19.13
  • FDBC $43.55
  • Resistance Level
  • TECX $21.46
  • FDBC $49.43
  • Average True Range (ATR)
  • TECX 1.27
  • FDBC 1.25
  • MACD
  • TECX -0.00
  • FDBC 0.71
  • Stochastic Oscillator
  • TECX 70.50
  • FDBC 91.53

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.

Share on Social Networks: